Paul Rennie

Paul Rennie

Amministratore Delegato presso PARADIGM BIOPHARMACEUTICALS LIMITED

Patrimonio netto: 2 M $ in data 30/06/2026

Health Technology
Distribution Services

Profilo

Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., where he currently holds the title of Executive Chairman & Managing Director.
Paradigm Biopharmaceuticals Ltd. was founded in 2014.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd. as Non-Executive Chairman, Stiefel Research Australia Pty Ltd. as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd. as Manager-Business Development, Mesoblast Ltd. as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd. as Manager-Sales & Marketing.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
18/06/2026 21.409.425 ( 3,66% ) 2 M $ 30/06/2026

Posizioni attive di Paul Rennie

SocietàPosizioneInizio
PARADIGM BIOPHARMACEUTICALS LIMITED Amministratore Delegato 22/11/2022

Precedenti posizioni note di Paul Rennie

SocietàPosizioneFine
NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED Amministratore Delegato 11/09/2023
Corporate Officer/Principal -
MERCK KGAA Vendite & Marketing -
Roche Diagnostics Australia Pty Ltd.
Vendite & Marketing -
MESOBLAST LIMITED Direttore operativo -
Vedi nel dettaglio l'esperienza di Paul Rennie

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

5

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Distribution Services

Health Technology

Health Technology

Roche Diagnostics Australia Pty Ltd.

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Paul Rennie